Novel Therapeutic Targets in Neuropsychiatric Disorders: The Neuroepigenome

E-ISSN： 1873-4286|20|11|1831-1839

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.11, 2014-04, pp. : 1831-1839

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Role of Zonisamide in Neuropsychiatric Disorders

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-09 ,pp. : 968-975

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

By Holmes A. Heilig M. Rupniak N.M.J. Steckler T. Griebel G.

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 580-588

Elsevier

Access to resources Recommend Favorite

Steroid 5-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 151-167

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutic targets in chordoma

By Bydon Mohamad Papadimitriou Kyriakos Witham Timothy Wolinsky Jean-Paul Bydon Ali Sciubba Daniel Gokaslan Ziya

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1139-1143

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutic targets in osteoporosis

By Tobias JH Flanagan AM Scutt AM

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 41-56

Informa Healthcare

Access to resources Recommend Favorite